Atlas

FDA-Inspected Site

Belcher Pharmaceuticals LLC

17 FDA inspections are on record for Belcher Pharmaceuticals LLC in Largo, United States.

Clean· No action indicated

Largo, United States · Last updated July 10, 2026

Overview

  • 17 FDA inspections are on record.
  • 10 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-02-07.

At a glance

Inspections

17

Form 483s

10

EIRs

3

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
3 Feb 2025 – 7 Feb 2025Animal Drugs & FeedsClean
7 Aug 2024 – 16 Aug 2024Human Drugs483View 483 →
31 Oct 2022 – 4 Nov 2022Human Drugs483View 483 →
1 Nov 2021 – 15 Nov 2021Human Drugs483View 483 →
20 May 2019 – 24 May 2019Human DrugsClean
20 Feb 2018 – 1 Mar 2018Human Drugs483View 483 →
25 Apr 2016 – 13 May 2016Human Drugs483View 483 →
10 Mar 2015Medical Devices & Rad HealthClean
17 Nov 2014 – 21 Nov 2014Human Drugs483View 483 →
22 Jan 2014 – 3 Feb 2014Human DrugsClean
15 Jan 2014 – 3 Feb 2014Human Drugs483On file
7 Jan 2013Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

16 Aug 2024
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Kayla V Sprague, Jessica P Mcalister

16 Aug 2024
21 CFR 211.165(b)

Microbiological testing

Cited by Kayla V Sprague, Jessica P Mcalister

16 Aug 2024
21 CFR 211.167(c)

Controlled release dosage form testing

Cited by Kayla V Sprague, Jessica P Mcalister

16 Aug 2024
21 CFR 211.42(c)(10)(iii)

Air Supply

Cited by Kayla V Sprague, Jessica P Mcalister

16 Aug 2024
FDCA 503B(a)(10)(A)

Drug product labels, fails to include

Cited by Kayla V Sprague, Jessica P Mcalister

Investigators

FDA investigators tied to this site in the record.

Nicole E Knowlton5 insp.
Jennifer A Robinson2 insp.
Kayla V Sprague1 insp.
Jessica P Mcalister1 insp.
Saundrea A Munroe1 insp.
Harshal J Desai1 insp.
Brittny C Cargo1 insp.
Steven A Brettler1 insp.
Laura L Staples1 insp.
Ladislav Kermet1 insp.
Ileana Barreto-Pettit1 insp.
Christos G Tsingelis1 insp.
Christie A Soto1 insp.
Jessica L Pressley1 insp.
Jennifer Lalama1 insp.
Miguel A Martinez1 insp.
Stephanie D Crockett1 insp.
Melanie W Pishnery1 insp.
Melanie G Warzala1 insp.
Tamara M Casselman1 insp.
Michael H Tollon1 insp.
Daveta L Bailey1 insp.
Jose A Lopez Rubet1 insp.
Salvatore N Randazzo1 insp.
Sarah E Mcmullen1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations9x
21 CFR 211.192Cited across public-safe Form 483 observations8x
21 CFR 211.25(a)Cited across public-safe Form 483 observations8x
21 CFR 211.100(b)Cited across public-safe Form 483 observations6x
21 CFR 211.165(e)Cited across public-safe Form 483 observations6x
21 CFR 211.170(b)Cited across public-safe Form 483 observations6x
21 CFR 211.194(d)Cited across public-safe Form 483 observations6x
21 CFR 211.22(d)Cited across public-safe Form 483 observations6x
21 CFR 310.305(a)Cited across public-safe Form 483 observations6x
21 CFR 211.100(a)Cited across public-safe Form 483 observations5x
21 CFR 211.160(b)Cited across public-safe Form 483 observations4x
21 CFR 211.111Cited across public-safe Form 483 observations2x
21 CFR 211.188Cited across public-safe Form 483 observations2x
21 CFR 211.194(a)(2)Cited across public-safe Form 483 observations2x
21 CFR 211.22(c)Cited across public-safe Form 483 observations2x
21 CFR 211.42(c)Cited across public-safe Form 483 observations2x
21 CFR 211.52Cited across public-safe Form 483 observations2x
21 CFR 211.67(b)Cited across public-safe Form 483 observations2x
21 CFR 211.165(b)Cited across public-safe Form 483 observations1x
21 CFR 211.167(c)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iii)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 314.80(c)(2)Cited across public-safe Form 483 observations1x
FDCA 503B(a)(10)(A)Cited across public-safe Form 483 observations1x
FDCA 503B(b)(2)(A)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Belcher Pharmaceuticals LLC's 10 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat